Citation

Trull MC, du Laney TV, Dibner MD. Nat. Biotechnol. 2007; 25(2): 179-184.

Affiliation

BioAbility, LLC, PO Box 14569, Research Triangle Park, North Carolina 27709, USA. mtrull@bioability.com

Copyright

(Copyright © 2007, Nature Publishing Group)

DOI

10.1038/nbt0207-179

PMID

17287749

Abstract

Five years after the US anthrax attacks, and more than two years after BioShield legislation was ratified, a survey reveals that biodefense funding has thus far produced only a handful of products for clinical development.

Language: en